259 filings
8-K
DXR
Daxor Corp.
25 Mar 24
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
2:00pm
N-CSR/A
DXR
Daxor Corp.
19 Mar 24
Certified annual shareholder report (management investment company) (amended)
5:23pm
N-CEN
DXR
Daxor Corp.
15 Mar 24
Annual report (registered investment company)
5:26pm
N-CSR
DXR
Daxor Corp.
15 Mar 24
Certified annual shareholder report (management investment company)
4:54pm
NT-NCSR/A
DXR
Daxor Corp.
8 Mar 24
Notice of inability to timely file Form N-CSR (amended)
1:49pm
NT-NCSR/A
20oixypa
29 Feb 24
Notice of inability to timely file Form N-CSR (amended)
5:28pm
NT-NCSR
v4j9bl7
29 Feb 24
Notice of inability to timely file Form N-CSR
4:15pm
CORRESP
t38jyx
14 Feb 24
Correspondence with SEC
12:00am
8-K
ftpm6
2 Jan 24
Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer
8:52am
8-K
cbl7tjtg28 v6q6n1p
27 Nov 23
Other Events
9:12pm
8-K
xhvt8w 46m
27 Oct 23
Other Events
5:27pm
N-CSRS
byno9 qdh3y
28 Aug 23
Certified semi-annual shareholder report (management investment company)
4:01pm
N-PX
pyt1q r62pe50q13hb1
15 Aug 23
Annual report of proxy voting record
7:14am
8-K
q2rjp 2wyqhy0xfljv4
13 Jul 23
Submission of Matters to a Vote of Security Holders
4:27pm
8-K
d10xht16fofrgw
25 May 23
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
7:04pm
N-CEN
r13fotp rurx3aofro
16 Mar 23
Annual report (registered investment company)
4:35pm
N-CSR
b4pj0ecgcge1 koi
1 Mar 23
Certified annual shareholder report (management investment company)
5:11pm
8-K
ego9tx0mrb9c8gshjg
21 Nov 22
Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
8:12am
N-CSR/A
m1vo68
14 Nov 22
Certified annual shareholder report (management investment company) (amended)
4:25pm